These findings suggest that, in this tumorigenic context of BrafV600E/Pten cKO, the tissue or cellular compartment of origin plays a dominant role in determining tumor phenotype, even when pro-melanoma signaling pathways are activated. This evidence concerns the gene PTEN and melanoma.